Gene-target recognition among members of the Myc superfamily and implications for oncogenesis

Myc and Mad family proteins regulate multiple biological processes through their capacity to influence gene expression directly. Here we show that the basic regions of Myc and Mad proteins are not functionally equivalent in oncogenesis, have separable E-box–binding activities and engage both common and distinct gene targets. Our data support the view that the opposing biological actions of Myc and Mxi1 extend beyond reciprocal regulation of common gene targets. Identification of differentially regulated gene targets provides a framework for understanding the mechanism through which the Myc superfamily governs the growth, proliferation and survival of normal and neoplastic cells.

[1]  R. DePinho,et al.  Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. , 1992, Genes & development.

[2]  B. Amati,et al.  Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. , 1994, Current opinion in genetics & development.

[3]  C. Dang,et al.  C-Myc transrepression and cell transformation. , 1997, Current topics in microbiology and immunology.

[4]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[5]  T. Lee,et al.  Myc represses transcription of the growth arrest gene gas1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[7]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[8]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[9]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[10]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[11]  R. DePinho,et al.  Repression by the Mad(Mxi1)‐Sin3 complex , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  R. Eisenman,et al.  Myc‐Max heterodimers activate a DEAD box gene and interact with multiple E box‐related sites in vivo. , 1996, The EMBO journal.

[13]  T. Halazonetis,et al.  Determination of the c-MYC DNA-binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[15]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[16]  A. Fornace,et al.  Myc represses the growth arrest gene gadd45 , 1997, Oncogene.

[17]  R. Eisenman,et al.  Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. , 1997, Genes & development.

[18]  C. Goding,et al.  Single amino acid substitutions alter helix‐loop‐helix protein specificity for bases flanking the core CANNTG motif. , 1992, The EMBO journal.

[19]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[20]  B. Amati,et al.  Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. , 1993, Nucleic acids research.

[21]  A. Ferré-D’Amaré,et al.  Structure and function of the b/HLH/Z domain of USF , 1994 .

[22]  G. Prendergast,et al.  c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. , 1994, The EMBO journal.

[23]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[24]  Y. Chen,et al.  Ratio-based decisions and the quantitative analysis of cDNA microarray images. , 1997, Journal of biomedical optics.

[25]  A. Krikos,et al.  Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.

[26]  R. Eisenman,et al.  Myc and Max function as a nucleoprotein complex , 1992, Current Biology.

[27]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[28]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[29]  G. Evan,et al.  The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.

[30]  Kou-Juey Wu,et al.  Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. , 1999, Science.

[31]  Y. Kyōgoku,et al.  Crystal structure of PHO4 bHLH domain–DNA complex: flanking base recognition , 1997, The EMBO journal.

[32]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[33]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[34]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[35]  D. Felsher,et al.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.